Pharmaceuticals & Biotechnology | Pharma & Biotech Resources
Summary: Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community Through Pharma IQ, you will be able to access pharmaceutical information resources such as
- Visit Website
- RSS
- Artist: Unknown
Podcasts:
Decreasing profits in pharmaceuticals over the past 5 years has put manufacturing and product costs under greater scrutiny. As a result there has been an increase in the need for a reduction in the size and cost of internal manufacturing and sourcing of cheaper products from external
Decreasing profits in pharmaceuticals over the past 5 years has put manufacturing and product costs under greater scrutiny. As a result there has been an increase in the need for a reduction in the size and cost of internal manufacturing and sourcing of cheaper products from external
The primary focus of Pharmacovigilance is patient safety. Raghavendra Pai, regional Pharmacovigilance Manager, Lundbeck Asia Pacific, explains the practical steps to train local pharmacovigilance staff to meet country-specific inspection and audit requirements, that also fit
With a population of 1.9 billion and a multi-medicine model, the reporting of adverse reactions in medicine in India is crucial. The pharmacovigilance programme was launched in India in 2010 to provide education about drug safety. Dr. Y.K Gupta, Co-ordinator of the national
Do you want to improve engagement levels during and after your webinar? In this interview Ken Molay, President of Webinar Success and prolific blogger on the subject of Web conferencing and its applications, speaks to Andrea Charles from Pharma IQ, about b est practices for
Do you want to improve engagement levels during and after your webinar? In this interview Ken Molay, President of Webinar Success and prolific blogger on the subject of Web conferencing and its applications, speaks to Andrea Charles from Pharma IQ, about b est practices for
Joanne Chio, Head of Clinical Trials at the Haematology- Oncology Research Group ( HORG), National University Cancer Institute, Singapore (NCIS), speaks to Andrea Charles from Pharma IQ about innovation in early phase trials. Chio also shares her insights on emerging trends in
Joanne Chio, Head of Clinical Trials at the Haematology- Oncology Research Group ( HORG), National University Cancer Institute, Singapore (NCIS), speaks to Andrea Charles from Pharma IQ about innovation in early phase trials. Chio also shares her insights on emerging trends in
There are mounting challenges around the sustainability of clinical trials as the pharmaceutical industry is faced with increasingly complex and expensive trials. But new models and collaberations are emerging, creating new opportunity around ways data is being captured
International Clinical Trials' Day will be celebrated on the 20th of May in order to celebrate the day that James Lind started his famous trial on the 20th of May 1747. In a series of interviews to celebrate this date, Pharma IQ spoke to Robert Smith, Clinical
Dr. Akhilesh Sharma, Senior Vice President and Global Head of Global Medical Affairs at Dr. Reddy's Laboratories, joins Andrea Charles from Pharma IQ, to discuss emerging trends in early phase clinical studies and the latest strategies Dr. Reddy's
Dr. Akhilesh Sharma, Senior Vice President and Global Head of Global Medical Affairs at Dr. Reddy's Laboratories, joins Andrea Charles from Pharma IQ, to discuss emerging trends in early phase clinical studies and the latest strategies Dr. Reddy's
The proportion of clinical trials in Phase I has increased significantly in the last number of years. This coupled with a number of Phase III failures has put increased emphasis on making the right decision as early as possible. Nancy Widener, Executive Director, Clinical Science and
The proportion of clinical trials in Phase I has increased significantly in the last number of years. This coupled with a number of Phase III failures has put increased emphasis on making the right decision as early as possible. Nancy Widener, Executive Director, Clinical Science and
Labelling and Artwork are still the highest causes of the recall of pharmaceutical products. Andrew Love, Vice President at Pharmaceutical Advisory Services, Be4ward Ltd, and former Director of Global Pack Management from GlaxoSmithKline, talks to Pharma IQ about his
